India's Marksans Pharma up on FDA nod to anti-cough drug

Marksans Pharma

22/08/2023 10:25

** Shares of Indian drugmaker Marksans Pharma  MARK.NS  rise
as much as 3.37% to 113.40 rupees 
    ** Co receives U.S. FDA approval for its abbreviated new
drug application of Guaifenesin extended-release tablets 
    ** Cough-treating tablets expected to launch immediately -
MARK
    ** YTD Marksans' shares up 91%

 (Reporting by Hritam Mukherjee in Bengaluru)
 ((Hritam.Mukherjee@thomsonreuters.com;))